Ticker Details
Relmada Therapeutics, Inc.
IPO Date:	June 16, 2014
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$683.47M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.54 | 4.29%
Avg Daily Range (30 D):	$0.22 | 3.26%
Avg Daily Range (90 D):	$0.25 | 3.96%

Institutional Daily Volume
Avg Daily Volume:	.26M
Avg Daily Volume (30 D):	1.42M
Avg Daily Volume (90 D):	1.67M

Trade Size
Avg Trade Size (Sh.):	132
Avg Trade Size (Sh.) (30 D):	82
Avg Trade Size (Sh.) (90 D):	90

Institutional Trades
Total Institutional Trades:	455
Avg Institutional Trade:	$2.19M
Avg Institutional Trade (30 D):	$3M
Avg Institutional Trade (90 D):	$2.22M
Avg Institutional Trade Volume:	.14M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.6M
Avg Closing Trade (30 D):	$4.93M
Avg Closing Trade (90 D):	$3.49M
Avg Closing Volume:	215.07K

News

Jun 29, 2026 @ 11:00 AM Relmada Therapeutics Joins Russell 2000® and Ru... Source: Na

May 5, 2026 @ 11:00 AM Relmada Therapeutics to Present NDV-01 Abstracts a... Source: Na

Mar 12, 2026 @ 11:00 AM Relmada Therapeutics to Report Fourth Quarter 2025... Source: Na

Feb 26, 2026 @ 5:07 PM Psychedelic Medicine Advances: Here Are Five Compa... Source: Prnewswire

Jul 31, 2025 @ 11:00 AM Relmada Therapeutics to Report Second Quarter 2025... Source: Corporate Communications

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-.22	$-.29	$-1.45
Diluted EPS	$-.22	$-.29	$-1.45
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-19.05M	$-19.87M	$-57.39M
Operating Income / Loss	$-19.46M	$-20.33M	$-59.1M
Cost of Revenue
Net Cash Flow	$6.28M	$2.11M	$-.36M
PE Ratio

Splits
Sep 30, 2019	1:4
Aug 12, 2015	1:5